Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-22

FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application to permit Amneal Pharmaceuticals NY LLC to market a generic combination oral contraceptive containing norethindrone acet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (Norethindrone acetate and ethinyl estradiol and ferrous fumarate)

Snippet

SUPPL AP for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)